Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
37.01
-0.07 (-0.19%)
At close: Mar 9, 2026, 4:00 PM EDT
37.01
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:52 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.96 billion as of March 9, 2026. Its market cap has increased by 567.00% in one year.
Market Cap
5.96B
Enterprise Value
5.18B
1-Year Change
567.00%
Ranking
Category
Stock Price
$37.01
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.96B, an increase of 4,696.40%. That is a compound annual growth rate of 98.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.82B |
| Kymera Therapeutics | 6.82B |
| Arcellx | 6.69B |
| Rhythm Pharmaceuticals | 6.39B |
| Protagonist Therapeutics | 5.88B |
| Immunovant | 5.43B |
| CRISPR Therapeutics AG | 5.42B |
| Celcuity | 5.32B |